Alexander M. Levine

Alexander M. Levine's AcademicInfluence.com Rankings

Alexander M. Levine

Philosophy

#6811

World Rank

#9914

Historical Rank

Logic

#3918

World Rank

#5148

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Alexander M. Levine Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Alexander M. Levine's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. (1984) (927)
Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. (1999) (519)
Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. (2005) (518)
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. (2005) (400)
Hepatitis C Virus Infection in Patients with B-Cell Non-Hodgkin Lymphoma (1997) (393)
Hepatitis C virus induces a mutator phenotype: Enhanced mutations of immunoglobulin and protooncogenes (2004) (359)
Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. (1997) (354)
Acquired immunodeficiency syndrome-related lymphoma [see comments] (1992) (314)
The effect of compliance with treatment on survival among patients with hematologic malignancies. (1990) (305)
Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy. (2001) (287)
Establishment of B-Cell Lymphoma Cell Lines Persistently Infected with Hepatitis C Virus In Vivo and In Vitro: the Apoptotic Effects of Virus Infection (2003) (274)
Development of B-cell lymphoma in homosexual men. Clinical and immunologic findings. (1984) (272)
Anemia in HIV infection: clinical impact and evidence-based management strategies. (2004) (262)
Determinants of HIV-1 shedding in the genital tract of women (2001) (250)
Human immunodeficiency virus‐related lymphoma. Prognostic factors predictive of survival (1991) (245)
Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. (1995) (239)
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. (2010) (229)
Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients. (2003) (222)
Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. (2003) (221)
Protease Inhibitor Use and the Incidence of Diabetes Mellitus in a Large Cohort of HIV‐Infected Women (2003) (216)
Improving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet). (2009) (207)
Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. (2005) (205)
AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. (2005) (201)
Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. (2005) (194)
Hepatitis C Virus Induces Toll-Like Receptor 4 Expression, Leading to Enhanced Production of Beta Interferon and Interleukin-6 (2006) (190)
AIDS-related malignant lymphoma: results of prospective treatment trials. (1987) (187)
Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study (2007) (184)
Hepatitis C Virus Infection Activates the Immunologic (Type II) Isoform of Nitric Oxide Synthase and Thereby Enhances DNA Damage and Mutations of Cellular Genes (2004) (183)
The influence of symptoms of disease and side effects of treatment on compliance with cancer therapy. (1988) (181)
Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial. (1991) (175)
Phase I Studies of Interleukin (IL)-2 and Rituximab in B-Cell Non-Hodgkin’s Lymphoma (2004) (172)
Pulmonary Kaposi's sarcoma: clinical findings and results of therapy. (1989) (171)
Changing patterns of anal canal carcinoma in the United States. (2013) (169)
Primary mediastinal lymphoma in adults. (1980) (165)
Evolving characteristics of AIDS-related lymphoma. (2000) (164)
Retrovirus and malignant lymphoma in homosexual men. (1985) (164)
Primary central nervous system lymphoma in homosexual men. Clinical, immunologic, and pathologic features. (1985) (164)
Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS). (1987) (163)
The Association of Race, Sociodemographic, and Behavioral Characteristics With Response to Highly Active Antiretroviral Therapy in Women (2005) (159)
Medically eligible women who do not use HAART: the importance of abuse, drug use, and race. (2004) (158)
Acquired immunodeficiency syndrome-related lymphoma. (1992) (156)
Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia. (2007) (153)
Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseas (1998) (153)
Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women. (2010) (150)
Prevalence and Correlates of Anemia in a Large Cohort of HIV‐Infected Women: Women's Interagency HIV Study (2001) (139)
Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. (2004) (133)
Primary central nervous system lymphoma in AIDS. Results of radiation therapy (1989) (133)
Association of Race and Gender With HIV‐1 RNA Levels and Immunologic Progression (2000) (132)
Impact of Highly Active Antiretroviral Therapy on Anemia and Relationship Between Anemia and Survival in a Large Cohort of HIV-Infected Women: Women’s Interagency HIV Study (2004) (131)
Trends in Mortality and Causes of Death Among Women With HIV in the United States: A 10-Year Study (2009) (130)
The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. (1996) (123)
Compliance with oral drug therapy in patients with hematologic malignancy. (1987) (123)
Functional Attributes of Mucosal Immunity in Cervical Intraepithelial Neoplasia and Effects of HIV Infection (2004) (121)
Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies (1998) (118)
Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). (1989) (116)
Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy. (2005) (114)
Prevalence and significance of acquired immunodeficiency syndrome-related retinal microvasculopathy. (1989) (111)
Acquired immunodeficiency syndrome-related lymphoma: clinical aspects. (2000) (110)
Role of health locus of control beliefs and expectations of treatment efficacy in adjustment to cancer. (1986) (102)
Marginal and Mixed-Effects Models in the Analysis of Human Papillomavirus Natural History Data (2010) (101)
Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG 149). (2000) (100)
Changes in sexual behavior among HIV-infected women after initiation of HAART. (2004) (100)
Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009. (2009) (100)
Neutropenia in human immunodeficiency virus infection: data from the women's interagency HIV study. (2006) (99)
Non-Hodgkin's lymphomas and other malignancies in the acquired immune deficiency syndrome. (1987) (98)
Cancer Risk Among Participants in the Women’s Interagency HIV Study (2004) (96)
Radiation therapy for acquired immunodeficiency syndrome-related Kaposi's sarcoma. (1988) (95)
Protease inhibitor levels in hair strongly predict virologic response to treatment (2009) (95)
A phase 1a clinical trial of LYM‐1 monoclonal antibody serotherapy in patients with refractory b cell malignancies (1989) (94)
Suramin antiviral therapy in the acquired immunodeficiency syndrome. Clinical, immunological, and virologic results. (1986) (93)
AIDS-related non-Hodgkin's lymphoma: abdominal CT findings in 112 patients. (1993) (92)
Suramin therapy in AIDS and related disorders. Report of the US Suramin Working Group. (1987) (92)
Immunoblastic sarcoma of T-cell versus B-cell origin: I. Clinical features (1981) (91)
Fracture incidence in HIV-infected women: results from the Women's Interagency HIV Study (2010) (91)
Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols (2005) (90)
Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma: association with diffuse large-cell subtype. (1994) (88)
The Prognostic Importance of Changes in CD4+ Cell Count and HIV-1 RNA Level in Women after Initiating Highly Active Antiretroviral Therapy (2004) (86)
Autopsy findings in AIDS‐related lymphoma (1988) (86)
Cervical Shedding of HIV-1 RNA Among Women With Low Levels of Viremia While Receiving Highly Active Antiretroviral Therapy (2007) (86)
Alcohol, tobacco and recreational drug use and the risk of non-Hodgkin's lymphoma. (1997) (84)
Human immunodeficiency virus hematology. (2003) (84)
Treatment of Advanced Kaposi's Sarcoma Using a Combination of Bleomycin and Vincristine (1990) (83)
Lymphomatoid granulomatosis: a T-cell disorder? (1982) (83)
Monoclonal antibody T101 in T cell malignancies: a clinical, pharmacokinetic, and immunologic correlation. (1986) (83)
Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women. (2007) (83)
Malignant lymphoma: cardiac involvement at initial presentation. (1987) (82)
Prevalence and Predictors of Metabolic Syndrome Among HIV-Infected and HIV-Uninfected Women in the Women's Interagency HIV Study (2008) (82)
Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of response. (2004) (81)
Peripheral T‐cell lymphoma (1989) (80)
Reproductive factors and risk of intermediate- or high-grade B-Cell non-Hodgkin's lymphoma in women. (2001) (79)
Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women. (2004) (78)
The New Face of Head and Neck Cancer: The HPV Epidemic. (2015) (78)
Clinical aspects and management of AIDS-related Kaposi's sarcoma. (2001) (78)
Total Lymphocyte Count, Hemoglobin, and Delayed-Type Hypersensitivity as Predictors of Death and AIDS Illness in HIV-1–Infected Women Receiving Highly Active Antiretroviral Therapy (2004) (77)
Lymphoma complicating immunodeficiency disorders. (1994) (75)
Physician Attitudes and Experience Regarding the Care of Patients With Acquired Immunodeficiency Syndrome (AIDS) and Related Disorders (ARC) (1987) (75)
Low incidence of invasive cervical cancer among HIV-infected US women in a prevention program (2003) (75)
Adenovirus-mediated granulocyte-macrophage colony-stimulating factor improves lung pathology of pulmonary alveolar proteinosis in granulocyte-macrophage colony-stimulating factor-deficient mice. (1998) (73)
Increase in Single-Tablet Regimen Use and Associated Improvements in Adherence-Related Outcomes in HIV-Infected Women (2014) (73)
Outcomes After Treatment of Cervical Intraepithelial Neoplasia Among Women With HIV (2007) (71)
Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease. (2002) (69)
Hepatitis C Virus Causes Uncoupling of Mitotic Checkpoint and Chromosomal Polyploidy through the Rb Pathway (2009) (68)
Long‐term incidence of cervical cancer in women with human immunodeficiency virus (2009) (66)
AIDS-related lymphoma. (1999) (66)
Successful therapy of convoluted T-lymphoblastic lymphoma in the adult. (1983) (65)
Neuropsychological functioning in a cohort of HIV- and hepatitis C virus-infected women (2005) (65)
Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial. (2016) (64)
Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS). (2009) (63)
Rectal lymphoma in homosexual men. (1986) (62)
Phase I study of antisense oligonucleotide against vascular endothelial growth factor: decrease in plasma vascular endothelial growth factor with potential clinical efficacy. (2006) (61)
Psychosocial status at initiation of cancer treatment and survival. (1990) (61)
Recent Advances in Acquired Immunodeficiency Syndrome (AIDS)‐related Lymphoma (2005) (60)
AIDS-associated malignant lymphoma. (1992) (60)
Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection. (2012) (60)
Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus. (2004) (60)
Small noncleaved follicular center cell (FCC) lymphoma: Burkitt and non‐Burkitt variants in the United States. I. Clinical features (1983) (59)
Peripheral blood mononuclear cell abnormalities and their relationship to clinical course in homosexual men with HIV infection. (1988) (59)
Initial studies on active immunization of HIV-infected subjects using a gp120-depleted HIV-1 Immunogen: long-term follow-up. (1996) (59)
Lymphoma in acquired immunodeficiency syndrome. (1990) (59)
Immunoblastic sarcoma. A clinical description (1979) (58)
Thrombotic thrombocytopenic purpura in patients with human immunodeficiency virus infection: A report of three cases and review of the literature (1992) (58)
Human herpesvirus 8 infection and Kaposi's sarcoma among human immunodeficiency virus-infected and -uninfected women. (2001) (58)
Association of race and gender with HIV-1 RNA levels and immunologic progression. (2000) (58)
The biology of tumor growth in the non-Hodgkin's lymphomas. A dual parameter flow cytometry study of 220 cases. (1984) (57)
Antiretroviral Therapy Exposure and Insulin Resistance in the Women's Interagency HIV Study (2008) (56)
Advanced acquired immune deficiency syndrome‐related Kaposi's sarcoma. Results of pilot studies using combination chemotherapy (1990) (55)
Treatment of HCV-related mantle-cell lymphoma with ribavirin and pegylated interferon Alfa. (2003) (55)
Positive Coombs test in Hodgkin's disease: significance and implications. (1980) (55)
Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma). (1999) (55)
Lung cancer incidence and survival among HIV-infected and uninfected women and men (2015) (54)
Mitoguazone therapy in patients with refractory or relapsed AIDS-related lymphoma: results from a multicenter phase II trial. (1997) (53)
HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV Study. (2010) (52)
Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women. (2005) (51)
Multidrug resistance (MDR-1) expression in AIDS-related lymphomas. (2002) (51)
HIV-1 RNA in plasma and genital tract secretions in women infected with HIV-1. (1999) (50)
Natural History of Grade 1 Cervical Intraepithelial Neoplasia in Women With Human Immunodeficiency Virus (2004) (49)
Effect of hormonal contraceptive use on plasma HIV-1-RNA levels among HIV-infected women (2003) (48)
B cell acute lymphocytic leukemia in adults. Clinical, morphologic, and immunologic findings. (1986) (47)
High‐Dose Cytosine‐Arabinoside and Cisplatin Regimens as Salvage Therapy for Refractory or Relapsed AIDS‐Related Non‐Hodgkin's Lymphoma (2001) (47)
Progressive Prothrombotic State in Women With Advancing HIV Disease (2006) (46)
Lymphoid follicles are generated in high-grade cervical dysplasia and have differing characteristics depending on HIV status. (2002) (46)
Disclosure of complementary and alternative medicine use to health care providers among HIV-infected women. (2009) (46)
Small noncleaved follicular center cell lymphoma: Burkitt's and non‐Burkitt's variants in the US II. Pathologic and immunologic features (1987) (45)
“The Pleasure Is Better as I’ve Gotten Older”: Sexual Health, Sexuality, and Sexual Risk Behaviors Among Older Women Living With HIV (2017) (45)
Insomnia symptoms and HIV infection among participants in the Women's Interagency HIV Study. (2012) (45)
Neuropsychological functioning in a cohort of HIV infected women: Importance of antiretroviral therapy (2002) (44)
Long-term cumulative detection of human papillomavirus among HIV seropositive women (2014) (44)
Epidemiology, clinical characteristics, and management of AIDS-related lymphoma. (1991) (44)
T-Cell Lymphoma in HIV-Infected Patients (2004) (44)
Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome‐related lymphoma: Effect on human immunodeficiency virus and serum interleukin‐6 levels over time (1996) (43)
Correlates of prevalent hypertension in a large cohort of HIV-infected women: Women's Interagency HIV Study (2007) (43)
Weekly docetaxel is safe and effective in the treatment of advanced‐stage acquired immunodeficiency syndrome‐related Kaposi sarcoma (2005) (42)
Challenges in the management of Burkitt's lymphoma. (2002) (41)
Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women. (2006) (41)
Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy. (2005) (41)
Use and efficacy of pneumococcal vaccine in patients with Hodgkin disease. (1979) (41)
Genital Warts and Vulvar Intraepithelial Neoplasia: Natural History and Effects of Treatment and Human Immunodeficiency Virus Infection (2011) (41)
Hematologic Aspects of HIV/AIDS. (2001) (41)
Immunotoxin combined with chemotherapy for patients with AIDS‐related non‐Hodgkin's lymphoma (1998) (40)
Virus-neutralizing activity, serologic heterogeneity, and retrovirus isolation from homosexual men in the Los Angeles area. (1986) (40)
Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte—macrophage colony‐stimulating factor in the treatment of AIDS‐related Kaposi's sarcoma (1992) (40)
HIV-associated Hodgkin's disease. Biologic and clinical aspects. (1996) (39)
Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS‐related Kaposi's sarcoma (1994) (39)
Phase I trial of m-BACOD and granulocyte macrophage colony stimulating factor in HIV-associated non-Hodgkin's lymphoma. (1993) (39)
The association of serum ferritin and transferrin receptor concentrations with mortality in women with human immunodeficiency virus infection. (2006) (38)
Cervical Precancer Risk in HIV-Infected Women Who Test Positive for Oncogenic Human Papillomavirus Despite a Normal Pap Test. (2015) (37)
HIV Tropism and Decreased Risk of Breast Cancer (2010) (36)
Management of AIDS-related lymphoma (2008) (36)
Making dendritic cells from the inside out: lentiviral vector-mediated gene delivery of granulocyte-macrophage colony-stimulating factor and interleukin 4 into CD14+ monocytes generates dendritic cells in vitro. (2004) (36)
Path model of multidimensional compliance with cancer therapy. (1987) (35)
Interleukin-4 in the treatment of AIDS-related Kaposi's sarcoma. (1997) (35)
Characteristics of indolent non‐hodgkin lymphoma in patients with type 1 human immunodeficiency virus infection (2002) (35)
Lack of association between hepatitis C infection and development of AIDS-related lymphoma. (1999) (35)
Increased Incidence of Central Venous Catheter‐Related Infections in Bone Marrow Transplant Patients (1995) (35)
Emergence of B-immunoblastic sarcoma in patients with multiple myeloma: a clinicopathologic study of 10 cases. (1982) (35)
Radiographic and radionuclide imaging in multiple myeloma: the role of gallium scintigraphy: concise communication. (1981) (34)
Randomized phase I/II study of troxacitabine combined with cytarabine, idarubicin, or topotecan in patients with refractory myeloid leukemias. (2003) (34)
The use of lentiviral vectors in gene therapy of leukemia: combinatorial gene delivery of immunomodulators into leukemia cells by state-of-the-art vectors. (2003) (34)
Epidemiological and biological study of acquired immunodeficiency syndrome-related lymphoma in the County of Los Angeles: preliminary results. (1992) (34)
A comparison of imaging, clinical, and pathologic aspects of space-occupying lesions within the brain in patients with acquired immune deficiency syndrome. (1986) (34)
Primary effusion lymphoma: successful treatment with highly active antiretroviral therapy and rituximab (2005) (33)
All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study. (1994) (33)
HPV testing for triage of HIV-infected women with papanicolaou smears read as atypical squamous cells of uncertain significance. (2004) (32)
Progressive histopathologic abnormalities in the persistent generalized lymphadenopathy syndrome. (1987) (32)
Use of mammographic screening by HIV-infected women in the Women's Interagency HIV Study (WIHS). (2002) (31)
Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047. (2013) (31)
Path Model of Multidimensional Compliance With Cancer Therapy (1987) (30)
A phase I/II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphoma (2007) (30)
Knowledge of cervical cancer prevention and human papillomavirus among women with HIV. (2010) (29)
Characterization of immunologic function in homosexual men with persistent, generalized lymphadenopathy and acquired immune deficiency Syndrome (1987) (29)
Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma. (2006) (29)
Once-weekly epoetin alfa improves quality of life and increases hemoglobin in anemic HIV+ patients. (2004) (29)
A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics, and Efficacy of ABT-263 in Subjects with Refractory or Relapsed Lymphoid Malignancies. (2007) (27)
Prevalence and Correlates of Highly Active Antiretroviral Therapy Switching in the Women's Interagency HIV Study (2002) (27)
Insulin-Like Growth Factor Axis and Oncogenic Human Papillomavirus Natural History (2008) (27)
Serological Detection of Human Papillomavirus Type 16 Infection in Human Immunodeficiency Virus (HIV)-Positive and High-Risk HIV-Negative Women (2006) (26)
Clinical Pharmacokinetics of the CD19 Receptor‐Directed Tyrosine Kinase Inhibitor B43‐Genistein in Patients with B‐Lineage Lymphoid Malignancies (1999) (26)
Evaluation and Management of HIV-Infected Women (2002) (25)
Hodgkin lymphoma: to the HAART of the matter (2006) (25)
Reversal of advanced renal dysfunction on bortezomib treatment in multiple myeloma patients (2005) (24)
Serum Biomarkers of Immune Activation and Subsequent Risk of Non-Hodgkin B-Cell Lymphoma among HIV-Infected Women (2013) (24)
The Relationship between Cocaine Use and Human Papillomavirus Infections in HIV-Seropositive and HIV-Seronegative Women (2008) (24)
Clinical, immunologic, and pathologic correlates of bone marrow involvement in 291 patients with acquired immunodeficiency syndrome-related lymphoma. (2001) (23)
Blood transfusions and the risk of intermediate- or high-grade non-Hodgkin's lymphoma. (1998) (23)
Outcome After Negative Colposcopy Among Human Immunodeficiency Virus–Infected Women With Borderline Cytologic Abnormalities (2005) (23)
Role of zidovudine antiretroviral therapy in the pathogenesis of acquired immunodeficiency syndrome-related lymphoma. (1995) (23)
Gender-Related Risk Factors Improve Mortality Predictive Ability of VACS Index Among HIV-Infected Women (2015) (22)
Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium (2016) (22)
Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in blood. (2009) (22)
CHEMOTHERAPY FOR HIV-ASSOCIATED NON-HODGKIN LYMPHOMA (HIV-NHL) IN COMBINATION WITH HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) IS NOT ASSOCIATED WITH EXCESSIVE TOXICITY. (1999) (22)
Orbital and adnexal lymphomas. A multiparameter approach. (1980) (22)
Correlates of CD4+ and CD8+ lymphocyte counts in high-risk immunodeficiency virus (HIV)-seronegative women enrolled in the women's interagency HIV study (WIHS). (2007) (22)
Serum beta‐2 microglobulin levels in homosexual men with aids and with persistent, generalized lymphadenopathy (1986) (21)
Cladribine in the treatment of advanced relapsed or refractory low and intermediate grade non‐Hodgkin's lymphoma (1998) (21)
The relation of plasmacytoid dendritic cells (pDCs) and regulatory T-cells (Tregs) with HPV persistence in HIV-infected and HIV-uninfected women. (2014) (21)
Non-AIDS-defining cancers and HIV infection (2005) (20)
Cognitive function in asymptomatic HIV infection. (1997) (19)
Treatment of epidemic Kaposi's sarcoma with combination chemotherapy (vincristine and bleomycin) and zidovudine. (1990) (19)
Factors associated with incident self-reported AIDS among women enrolled in the women's interagency HIV study (WIHS). WIHS Collaboratorive Study Group. (2000) (19)
Cytarabine, cisplatin, and etoposide chemotherapy for refractory non-Hodgkin's lymphoma. (1987) (19)
Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma. (2001) (18)
Marginal zone lymphoma. (2006) (18)
Accuracy of diagnoses of HIV-related oral lesions by medical clinicians. Findings from the Women's Interagency HIV Study. (2001) (18)
Retinopathy before the diagnosis of AIDS. (1989) (18)
Non—AIDS–Defining cancers and HIV infection (2005) (17)
The use of fine needle aspiration cytology in the management of human immunodeficiency virus-related non-Hodgkin's lymphoma and Hodgkin's disease. (1993) (17)
Immunoblastic sarcoma of T-cell versus B-cell origin: I. Clinical features. (1981) (17)
AIDS-related lymphoma. (2006) (17)
Longitudinal Trends in Sexual Behaviors with Advancing Age and Menopause Among Women With and Without HIV-1 Infection (2015) (17)
AIDS-related malignant lymphoma: clinical presentation and treatment approaches. (1987) (16)
Interleukin 10 responses are associated with sustained CD4 T-cell counts in treated HIV infection. (2012) (16)
The long-term use of zidovudine in patients with severe immune-mediated thrombocytopenia secondary to infection with HIV. (1991) (16)
Malignancies in the acquired immunodeficiency syndrome. (1987) (16)
Analysis of physician attitudes concerning requests for autopsy. (1994) (16)
AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma. (1997) (16)
Results of initial lymph node biopsy in homosexual men with generalized lymphadenopathy. (1986) (15)
Heterogeneity of response and survival in diffuse histiocytic lymphoma after bacop therapy (bleomycin, doxorubicin, cyclophosphamide, vincristine, prednisone) (1985) (15)
Trends in Nonlipid Cardiovascular Disease Risk Factor Management in the Women's Interagency HIV Study and Association with Adherence to Antiretroviral Therapy. (2016) (15)
Cervicovaginal human papillomavirus (HPV)‐infection before and after hysterectomy: evidence of different tissue tropism for oncogenic and nononcogenic HPV types in a cohort of HIV‐positive and HIV‐negative women (2012) (14)
Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. (2003) (14)
Acute leukemias with both myeloid and lymphoid surface markers. Cytoplasmic alpha-1-anti-chymotrypsin and alpha-1-anti-trypsin as possible indicators of early granulocytic differentiation. (1986) (13)
Hepatitis C and B-Cell Lymphoma (1998) (13)
Clinical and Immunologic Spectrum of Plasmacytoid Lymphocytic Lymphoma without Serum Monoclonal IgM (1980) (13)
Antithrombin III and anti‐activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin (1982) (13)
Clinical, Immunologic, and Pathologic Features (1985) (12)
Immunohistology of persistent generalized lymphadenopathy. Evidence for progressive lymph node abnormalities in some patients. (1987) (12)
Red hair and hyperpigmentation in a black man after chemotherapy. (1987) (12)
Efficacy and toxicity of concurrent rituximab plus infusional EPOCH in HIV-associated lymphoma: AIDS Malignancy Consortium Trial 034 (2008) (12)
PROGNOSTIC FACTORS IN THE TREATMENT OF HIV-ASSOCIATED NON-HODGKIN LYMPHOMA (HANHL): ANALYSIS OF ACTG 142(LOW-DOSE VS. STANDARD-DOSE mBACOD + GM-CSF) (1997) (11)
HIV-related malignant lymphoma: clinical aspects, treatment, and pathogenesis. (1988) (11)
Histologic Correlates of Glandular Abnormalities in Cervical Cytology Among Women With Human Immunodeficiency Virus (2009) (11)
Serum erythropoietin titers in patients with human immunodeficiency virus (HIV) infection and anemia. (1991) (11)
Association of complementary and alternative medicine use with highly active antiretroviral therapy initiation. (2008) (11)
Antithrombin III and anti‐activated factor × activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin (1983) (11)
Cytofluorographic analysis of lymph nodes from patients with the persistent generalized lymphadenopathy (PGL) syndrome. (1985) (11)
Association of cells with natural killer (NK) and NKT immunophenotype with incident cancers in HIV-infected women. (2008) (11)
Association of cutaneous anergy with human papillomavirus and cervical neoplasia in HIV-seropositive and seronegative women (2007) (11)
Therapeutic approaches to neoplasms in AIDS. (1990) (10)
Effect of Stress and Depression on the Frequency of Squamous Intraepithelial Lesions (2011) (10)
Identification of T‐ and B‐cell epitopes associated with a restricted component of the epstein‐barr virus‐induced early antigen complex (1993) (10)
PRELIMINARY RESULTS OF AIDS CLINICAL TRIALS GROUP (ACTG) STUDY #149: PHASE II TRIAL OF ABVD CHEMOTHERAPY WITH G-CSF IN HIV INFECTED PATIENTS WITH HODGKIN'S DISEASE (HD): S7 (1997) (10)
Treatment of Non-APL Acute Myelogenous Leukemia with Intravenous Arsenic Trioxide Plus Ascorbic Acid. (2005) (9)
Prevalence and Predictors of Hospitalizations Among HIV-Infected and At-Risk HIV-Uninfected Women (2017) (9)
Seroprevalence of HTLV-I and HTLV-II among a cohort of HIV-infected women and women at risk for HIV infection. Women's Interagency HIV Study. (1998) (9)
Early clinical markers and CD4 percentage in subjects with human immunodeficiency virus infection. (1996) (9)
Marijuana Use is Not Associated with Cervical Human Papillomavirus Natural History or Cervical Neoplasia in HIV-Seropositive or HIV-Seronegative Women (2010) (9)
Large noncleaved follicular center cell lymphoma clinical features in 53 patients (1986) (9)
Incidence and management of AIDS-related lymphoma. (2001) (9)
Open-label phase I study of combination therapy with zidovudine and interferon-beta in patients with AIDS-related Kaposi's sarcoma: AIDS Clinical Trials Group Protocol 057. (1998) (9)
Simultaneous occurrence of Pneumocystis carinii pneumonia, cytomegalovirus infection, Kaposi's sarcoma, and B-immunoblastic sarcoma in a homosexual man. (1985) (9)
B-cell lymphoma in two monogamous homosexual men. (1985) (9)
Pharmacokinetic profile of Mitoguazone (MGBG) in patients with AIDS related non-Hodgkin's lymphoma (2004) (9)
Elevated serum levels of CXCL13 precede HIV-associated non-Hodgkin’s lymphoma (2010) (8)
Interferon-alpha maintenance therapy after cytotoxic chemotherapy for treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. (1990) (8)
Intravenous immunoglobulin in the treatment of human immunodeficiency virus‐related thrombocytopenia (1991) (8)
Malignancies in Women with HIV Infection (2008) (8)
Correlating Knowledge of Cervical Cancer Prevention and Human Papillomavirus With Compliance After Colposcopy Referral (2012) (8)
Moving Toward Economically Sustainable Value-Based Cancer Care in the Academic Setting. (2015) (8)
An effective reinduction regimen for first relapse of adult acute lymphoblastic leukemia (2013) (8)
AIDS-related malignancies. (1994) (8)
Thrombocytopenia Is a Strong Predictor of All-Cause and AIDS-Specific Mortality in Women with HIV: The Women’s Interagency HIV Study. (2004) (7)
Human retrovirus-associated lymphoproliferative disorders in homosexual men. (1986) (7)
Association between complementary and alternative medicine use and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study. (2007) (7)
LOW DOSE PACLITAXEL (TAXOL⊙) IS HIGHLY EFFECTIVE IN THE TREATMENT OF PATIENTS WITH ADVANCED AIDS-RELATED KAPOSI'S SARCOMA: 77 (1997) (7)
AIDS-Related Cancers and Their Treatment (2000) (7)
Relationship between complementary/alternative treatment use and illicit drug use among a cohort of women with, or at risk for, HIV infection. (2010) (7)
Prevalence and correlates of highly active antiretroviral therapy switching in the Women's Interagency HIV Study. (2002) (6)
Assumed Similarity of Attitudes About AIDS Among Gay and Heterosexual Physicians (1988) (6)
HIV-associated lymphoma. (2010) (6)
PRELIMINARY RESULTS OF PEG-L-ASPARAGINASE (ONCASPAR) IN THE TREATMENT OF RELAPSED/ REFRACTORY AIDS-RELATED LYMPHOMAS. (1998) (6)
The treatment of AIDS-related cancers. (2003) (6)
Human immunodeficiency virus‐related lymphoma: Prognostic factors predictive of survival (1993) (6)
Epidemiology of Malignancies in HIV/AIDS (2000) (6)
Genital Tract HIV RNA Levels and Their Associations With Human Papillomavirus Infection and Risk of Cervical Precancer (2014) (6)
Viral load, CD4 percentage, and delayed-type hypersensitivity in subjects receiving the HIY-1 Immunogen and antiviral drug therapy (1996) (6)
Treatment of AIDS Related Non-Hodgkin's Lymphoma with Combination Mitoguazone Dihydrochloride and Low Dose Chop Chemotherapy: Results of a Phase II study (2004) (6)
Cyclic eosinophilic leukocytosis in eosinophilic leukemia with observations on transcobalamin I and eosinophils (1984) (6)
Monoclonal gammopathy associated with HIV infection. (2006) (6)
Combination treatment approaches and novel therapies for lymphoma. (2007) (6)
Anemia in the setting of cancer and human immunodeficiency virus. (2003) (5)
Immunophenotypic analysis of peripheral blood leukocytes at different stages of HIV infection. An analysis of asymptomatic, ARC, and AIDS populations. (1989) (5)
Phase I trial of anti-sense oligonucleotide vascular endothelial growth factor (VEGF-AS, Veglin) in patients with relapsed and refractory malignancies (2004) (5)
Lymphomas and leukemias due to infectious organisms (2012) (5)
Phase I Study of the [Cu, Zn] Superoxide Dismutase (SOD1) Inhibitor ATN-224 (Bis-Choline Tetrathiomolybdate) in Patients (pts) with Advanced Hematologic Malignancies. (2006) (5)
Different Localization of Dendritic Cell Reservoirs in Human Immunodeficiency Virus-1 Subtype B Versus Subtype E-infected Lymph Nodes (2003) (5)
Angiogenesis and hematological malignancies (2005) (5)
Dysregulated B-cell TLR2 expression and elevated regulatory B-cell frequency precede the diagnosis of AIDS-related non-Hodgkin lymphoma (2015) (4)
Treatment of Acute Myelogenous Leukemia (non-APL) with Intravenous Trisenox® (Arsenic Trioxide) and Ascorbic Acid: Preliminary Results. (2004) (4)
Short-term garlic supplementation and highly active antiretroviral treatment adherence, CD4+ cell counts, and human immunodeficiency virus viral load. (2012) (4)
An investigation of the possible interaction between the use of Vitamin C and highly active antiretroviral therapy (HAART) adherence and effectiveness in treated HIV+ women. (2012) (4)
CERVICOVAGINAL HUMAN PAPILLOMAVIRUS INFECTION IN HIV-POSITIVE AND HIGH RISK HIV-NEGATIVE WOMEN: S3 (1997) (4)
ACQUIRED IMMUNODEFICIENCY SYNDROME-RELATED LYMPHOMA. AUTHOR REPLY (1992) (4)
A phase II trial of pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone (DR-COP) in aggressive B-cell non-Hodgkin's lymphoma (2004) (4)
Intravenous immune globulin use in patients with human immunodeficiency virus-related thrombocytopenia who require dental extraction. (1991) (4)
Phase I Study of Noscapine for Patients with Non-Hodgkin’s Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy. (2005) (3)
Sensitization of AIDS related non-Hodgkin's B lymphoma cell lines to cytotoxic drugs toxins by interferon-gamma. (1996) (3)
NON AIDS DEFINING MALIGNANCIES AMONG 5, 574 HIV SEROPOSITIVE MEMBERS OF A LARGE MANAGED CARE-BASED COHORT. (1998) (3)
Phase I trial of anti-sense oligonucleotide vascular endothelial growth factor (VEGF-AS, Veglin) in patients with relapsed and refractory malignancies. (2004) (3)
Hodgkin's disease in the setting of HIV infection. (1993) (3)
Small cleaved follicular center cell lymphoma: seven cases in California plumbers. (1983) (3)
Incidence and risk factors for lung cancer among women in the women’s interagency HIV study (WIHS) and men in the multicenter AIDS cohort study (MACS) (2012) (3)
Efficacy of epoetin alfa administered every 2 weeks to maintain hemoglobin and quality of life in anemic HIV-infected patients. (2008) (3)
Managing Anemia in HIV-Positive Women (2006) (3)
Malignant Lymphoma in Homosexual Men: Clinical and Pathologic Details of Disease (1985) (3)
Evolving Characteristics of AIDS-Related Lymphoma (ARL) Over Time: A Single Institution Study of 369 Patients: (1999) (3)
Treatment of Anemia with Aranesp® (Darbepoetin-alfa) Given Once Every Two Weeks in HIV Seropositive Patients. (2004) (2)
Editorial response : Regression of AIDS-related Kaposi's sarcoma during therapy with thalidomide (1996) (2)
A phase I/II trial of liposomal doxorubicin (tlc-d99, myocet) in combination with cyclophosphamide, vincristine, and prednisone (comp) for newly diagnosed intermediate and high grade non-Hodgkin's lymphoma (nhl) (2001) (2)
Antiviral effects of suramin in patients with the acquired immunodeficiency syndrome (1987) (2)
Stem cell transplantation in AIDS-lymphoma. (2009) (2)
Reconstitution of T-cell function in aids and ARC patients by use of the endogenous, leukocyte-derived immunomodulator, IMREG-1 (1985) (2)
Clinical Manifestations of T-Cell Lymphomas (1980) (2)
Non-Hodgkin's lymphomas: clinical features (1985) (2)
Anti-retroviral therapy and cognitive function. (1997) (2)
Compliance with chemotherapy: theoretical basis and intervention design. (1983) (2)
An IELSG International Survey of Primary Effusion Lymphoma (PEL). (2004) (2)
Cancer in AIDS Editorial overview (1990) (2)
TREATMENT OF AIDS LYMPHOMA WITH HIGH‐DOSE CHEMOTHERAPY AND GENETICALLY MODIFIED STEM CELLS: A MODEL FOR EVALUATION OF GENE THERAPY.: ABSTRACT S19 (2000) (2)
A phase I/II trial of BBR-2778 (pixantrone), methylprednisolone, cisplatin, and cytosine arabinoside (BSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphoma (NHL). (2004) (2)
Induction of Complete Remission Using Single Agent Clofarabine in a Patient with Primary Refractory Acute Myeloblaste Leukemia (2003) (2)
189 HIV Tropism and Decreased Risk of Breast Cancer (2011) (2)
Cancer in AIDS. (1992) (2)
Results of a pilot trial of fludarabine, mitoxantrone and rituximab in mantle cell lymphoma. (2004) (2)
Burkitt's lymphoma and previous AIDS-defining illnesses are not prognostic factors in AIDS-related non-Hodgkin's lymphoma. Authors' reply (2005) (1)
Interleukin-l 0 Is an Autocrine Growth Factor for Acquired Immunodeficiency Syndrome-Related B-Cell Lymphoma (2000) (1)
Management of the patient with large cell lymphoma. (1988) (1)
Development of Prothrombotic Repertoire with Progressive HIV Disease: Data from the Women’s Interagency HIV Study (WIHS). (2004) (1)
Diagnosis and Treatment of Non–Hodgkin’s Lymphoma in the Patient with AIDS (2000) (1)
Evaluation of Immune Recovery Following Autologous Hematopoietic Cell Transplantation in HIV-Related Lymphoma: Results of the BMT CTN 0803/AMC 071 Trial (2016) (1)
Marijuana use and cervical HPV/neoplasia (2009) (1)
Risk of Breast Cancer With CXCR4-Using HIV Defined by V3 Loop Sequencing (2015) (1)
Results of a Pilot Trial of Fludarabine, Mitoxantrone and Rituxan in Mantle Cell Lymphoma. (2005) (1)
Phase II trial of pegylated liposomal doxorubicin (PLD), rituxan, cyclophosphamide, vincristine, and prednisone in aggressive B-cell non-Hodgkin's lymphoma (2008) (1)
Flow cytometric lymphocyte immunophenotyping in homosexual men with the persistent generalized lymphadenopathy syndrome: a longitudinal study of lymph nodes and blood. (1987) (1)
The Treatment of AIDS-Related Lymphoma-Reply (1992) (1)
The Pharmacokinetics, Safety and Lack of Antibody Production from Multiple Doses of Intravenous Pegylated Asparaginase in Adults with Newly Diagnosed Acute Lymphoblastic Leukemia. (2006) (1)
UNUSUAL CASES OF BREAST CANCER IN HIV INFECTED WOMEN: WOMEN'S INTERAGENCY HIV STUDY (WIHS). (1997) (1)
A Phase 2 Study of the Thrombospondin-Mimetic Peptide ABT-510 in Patients with Refractory Lymphoma. (2005) (1)
Incidence and risk factors for lung cancer among women in the women's interagency HIV study (WIHS) and men in the multicenter AIDS cohort study (MACS) (2012) (1)
Human T-cell lymphotropic virus type III associated disorders. The spectrum in the heterosexual population. (1986) (1)
Radiosensitivity of skin fibroblasts from patients with aids-related kaposps sarcoma (1993) (1)
Sensitivity of drug-resistant B-cell lines from AIDS-related non-hodgkins-lymphoma to newly synthesized podophyllotoxin derivatives and aza-alkyllysophospholipids - enhanced sensitization by pretreatment with interferon-gamma. (1994) (1)
A phase II trial of pegylated doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone (DR-COP) in patients with newly diagnosed AIDS-associated B-cell non-Hodgkin's lymphoma (ARL): An AIDS Malignancy Consortium trial (AMC 047). (2010) (1)
157 Phase I trial of an antisense to vascular endothelial growth factor (VEGF-AS, Veglin) in relapsed and refractory malignancies (2004) (1)
Non–Hodgkin’s Lymphoma (2016) (0)
MOBILIZATION OF PERIPHERAL BLOOD PROGENITOR CELLS (PBPC) AND ENGRAFTMENT FOLLOWING HIGH‐DOSE CHEMOTHERAPY FOR AIDS‐LYMPHOMA: ABSTRACT 60 (2000) (0)
Vaccination and autoimmunity (2004) (0)
A Multivariate Clinical and Economic Model for Predicting Risk-Based Costs of Care for Acute Leukemia (AL) Patients (Pts) Undergoing Allogeneic Hematopoietic Cell Transplant (HCT) (2016) (0)
TREATMENT OF RELAPSED/REFRACTORY AIDS‐RELATED LYMPHOMAS (AIDS‐NHL) WITH HIGH DOSE CYTARABINE(ARAC)/CISPLATIN COMBINATION REGIMENS: ABSTRACT 37 (2000) (0)
PEG-L-ASPARAGINASE HAS ACTIVITY IN RELAPSED/REFRACTORY AIDS-RELATED LYMPHOMAS. (1999) (0)
Anal Squamous Intraepithelial Lesions in HIV-Positive Men and Women (2016) (0)
CONTINUOUS INFUSION GALLIUM NITRATE IN REFRACTORY AIDS ASSOCIATED LYMPHOMA. (1999) (0)
AIDS-lymphoma (ARL): one more step along the way. (2013) (0)
Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial (1991) (0)
Randomized P hase I /II S tudy o f T roxacitabine C ombined W ith Cytarabine, I darubicin, o r T opotecan i n P atients W ith Refractory M yeloid L eukemias (2003) (0)
Lymphoproliferative Disordersin Patients at Risk for AIDS: Reactiveand Neoplastic (1986) (0)
Treatment-Relate d M yelodysplasia a nd A cute L eukemia i n Non-Hodgkin's L ymphoma P atients (2003) (0)
Lymphoproliferative Disorders in Patients at Risk for AIDS : Reactive and Neoplastic (1986) (0)
Letter from Alexandra M. Levine, University of Southern California Comprehensive Cancer Center to Harold Varmus (1985) (0)
T-CELL LYMPHOMAS IN PATIENTS WITH HIV INFECTION: A REPORT OF 5 CASES FROM A SINGLE INSTITUTION (1997) (0)
Letter to the editorLymphomatoid granulomatosis: A T-cell disorder? (1983) (0)
Rapid development of HPV-mediated oropharyngeal squamous cell carcinoma in the setting of immune suppression following autologous stem cell transplantation for Hodgkin lymphoma (2017) (0)
Serum prevalence of B cell stimulatory TLR ligands, elevated B cell TLR2 expression and regulatory B cell frequency precede the genesis of HIV-non-Hodgkin’s lymphoma (NHL) in ART treated HIV+ subjects (TUM7P.951) (2014) (0)
SupportScreen: A prospective automated approach to real-time symptom and problem identification, triage, and tailored education. (2013) (0)
HPV-Related Neoplasia in HIV Infection (2016) (0)
Chemotherapy f or H uman I mmunodeficiency Virus-Associated N on-Hodgkin's L ymphoma i n Combination W ith H ighly A ctive A ntiretroviral T herapy (2001) (0)
City of Hope's referring physician communication process improvement initiative. (2013) (0)
HIV tropism and decreased risk of breast cancer among women in the United States (2010) (0)
Identifying the Cognitive Decrements Caused by HIV. (1994) (0)
Surgical outcome in acquired immunodeficiency syndrome patients with non-Hodgkin's lymphoma of the gastrointestinal tract (1996) (0)
Third generation lentiviral vectors to boost an immune response against acute myeloid leukemia cells (2000) (0)
National Cancer Institute Resources for AIDS Oncology Research (2016) (0)
048: Cancer Risk Among Women in the WIHS and VAHS Cohorts (2005) (0)
Miscellaneous cancers associated with HIV infection. (1990) (0)
TLR4 signaling induces hepatocellular carcinomas by synergistic interactions between alcohol and hepatitis C virus (2008) (0)
MITOGUAZONE DIHYDROCHLORIDE (MGBG) IN COMBINATION WITH LOW DOSE CHOP FOR THE TREATMENT OF NEWLY DIAGNOSED AIDS-RELATED LYMPHOMA: 92 (1997) (0)
Efficacy of Epoetin Alfa 40,000 U SC Every 2 Weeks to Maintain Hemoglobin Levels in Anemic HIV-Infected Patients (2004) (0)
Neoplasms in Acquired Immunodeficiency Syndrome (2002) (0)
LIPOSOMAL DAUNORUBICIN (DAUNOXOME) IN RELAPSED/ REFRACTORY AIDS‐RELATED NON‐HODGKIN'S LYMPHOMAS (AIDS‐NHL).: ABSTRACT 61 (2000) (0)
Cancer in AIDS. (1993) (0)
A phase II trial of pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone (DR-COP) in aggressive B-cell non-Hodgkin's lymphoma. (2004) (0)
Human T-Lymphotropic Retrovirus (HTLV-III) Associated Lymphoproliferative Disorders in Homosexual Men (1985) (0)
Pertussis and Pertussis Vaccines in Adults (2016) (0)
RELATIONSHIP BETWEEN RECREATIONAL DRUG USE AND DEVELOPMENT OF AIDS-LYMPHOMA (AIDS-NHL). (1998) (0)
HIV-related neoplastic disease: 1991. (1991) (0)
Multi-Drug Resistance (MDR-1) in Newly Diagnosed AIDS-Lymphoma: (1999) (0)
Chapter 34 – Lymphoma in the Immunosuppressed (2006) (0)
AIDS Related Small Non-Cleaved (Burkitt or Atypical Burkitt) Lymphoma Versus Diffuse Large Cell Lymphoma in the Pre- and Post-HAART Eras: Significant Differences in Survival. (2004) (0)
Abstract 5728: HIV tropism and decreased risk of breast cancer among women in the United States (2010) (0)
Intraepithelial Neoplasia and Effects of HIV Infection Functional Attributes of Mucosal Immunity in Cervical Updated (2004) (0)
Prognostic factors in HIV-related diffuse large cell lymphoma (HIV-DLCL) in the pre and post-HAART (HT) era (2005) (0)
Pathology: lymphoma-correlating morphology and clinical course of disease. (1986) (0)
MULTI‐DRUG RESISTANCE (MDR‐1) IN HIV SEROPOSITIVE PATIENTS WITH HODGKIN'S DISEASE: ABSTRACT 62 (2000) (0)
Unique Lymphoma Marks Exposure to HTLV-III (1986) (0)
BONE MARROW (BM) INVOLVEMENT IN AIDS-LYMPHOMA (AIDS-NHL): CLINICAL, IMMUNOLOGIC AND PATHOLOGIC FEATURES. (1998) (0)
AIDS‐related malignancies: Commentary (1994) (0)
P60 Standardizing data collection by interviewers on a multi-site longitudinal research study (1996) (0)
HUMAN IMMUNODEFICIENCY VIRUS-RELATED LYMPHOMA : PROGNOSTIC FACTORS PREDICTIVE OF SURVIVAL. AUTHOR'S REPLY (1993) (0)
Update on HIV-Related Malignancies (2005) (0)
The City of Hope (COH) performance excellence program (PEP): A physician incentive program to improve health care performance (HCP) in an academic medical center. (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Alexander M. Levine?

Alexander M. Levine is affiliated with the following schools:

Alexander M. Levine's Academic­Influence.com Rankings

Why Is Alexander M. Levine Influential?

Alexander M. Levine's Published Works

Published Works

What Schools Are Affiliated With Alexander M. Levine?

Alexander M. Levine's AcademicInfluence.com Rankings